Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, s...
Taiwan headquartered Bora Biologics, a leading contract development and manufacturing organization (CDMO) specialis...
China-based WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has ...
Taiwan-based Bora Pharmaceuticals , a global leader in pharmaceutical manufacturing, has announced the appointment of Je...
Sanyou Biopharmaceuticals Co. and TransRecoBio Biotechnology Co. have signed a strategic cooperation agreement. The two ...
US-based AGC Biologics, a global Contract Development and Manufacturing Organisation (CDMO), has announced a multiphase ...
Merck, known as MSD outside of the United States and Canada, has announced the start of construction for a $1 billion, 4...
South Korea-based Lotte Biologics has signed a manufacturing agreement with an Asia-based biotech company for ...
BioDuro is expanding its global contract research, development and manufacturing organisation (CRDMO) network with the o...
AGC Biologics has announced a strategic decision about the large-scale single-use technology it will use at it...
The pharmaceutical sector, which is one of the highest emitters of carbon, is no exception. According to Deloitte, more ...
Xcell Biosciences Australia Pty Ltd, an Australian affiliate of the San Francisco-based instrumentation company focused ...
ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...
Amaran Biotechnology Inc., a subsidiary of OBI Pharma specialising in Contract Development and Manufacturing Organizatio...
WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced a significant exp...
Syngene International Limited, a global contract research, development, and manufacturing organization (CRDMO), has anno...
Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...
